title: Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseases.
authors.affiliation: National Institutes of Health, Bethesda, Maryland.
authors.forename: M E
authors.initials: ME
authors.lastname: Sanders
authors.forename: E L
authors.initials: EL
authors.lastname: Alexander
authors.forename: C L
authors.initials: CL
authors.lastname: Koski
authors.forename: M L
authors.initials: ML
authors.lastname: Shin
authors.forename: Y
authors.initials: Y
authors.lastname: Sano
authors.forename: M M
authors.initials: MM
authors.lastname: Frank
authors.forename: K A
authors.initials: KA
authors.lastname: Joiner
mesh_terms: D001327:Autoimmune Diseases / Q000134:cerebrospinal fluid* / Q000276:immunology; D003186:Complement C9 / Q000276:immunology; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins / Q000134:cerebrospinal fluid* / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000276:immunology; D011129:Polyradiculoneuropathy / Q000134:cerebrospinal fluid* / Q000276:immunology; D012859:Sjogren's Syndrome / Q000134:cerebrospinal fluid* / Q000276:immunology
chemical_list: D003186:Complement C9; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins